HopeStage
Back to all studies
CompletedNCT00732901

Escitalopram or placebo and serotonin in cocaine addiction

About this titleRead the official source — NCT00732901
Medication studyAges 18–55United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
HoustonSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2008
Recruitment status
Completed
Enrollment listed in the registry
160
Sponsor
Virginia Commonwealth University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT00732901
Official title
Show the full official title

Project 1: Clinical Neurobiology of Serotonin and Addiction

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Houston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Virginia Commonwealth University, a university.

Did this study involve medication?

Yes. The study involved medication, including Escitalopram and Placebo.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies